These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1078882)

  • 1. Nonspecific and specific immunosuppression in tumour-bearing mice by soluble immune complexes.
    Gorczynski RM; Kilburn DG; Knight RA; Norbury C; Parker DC; Smith JB
    Nature; 1975 Mar; 254(5496):141-3. PubMed ID: 1078882
    [No Abstract]   [Full Text] [Related]  

  • 2. Blocking of syngeneic effector T cells by soluble tumour antigens.
    Plata F; Levy JP
    Nature; 1974 May; 249(454):271-4. PubMed ID: 4545403
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunity to murine sarcoma virus-inducted tumors. I. Specific T lymphocytes active in macrophage migration inhibition and lymphocyte transformation.
    Gorczynski RM
    J Immunol; 1974 May; 112(5):1815-25. PubMed ID: 4361977
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic significance of nonspecific suppressor cells in spleens of tumor-bearing mice.
    Hanna N; Kripke ML
    Cell Immunol; 1979 Mar; 43(2):293-303. PubMed ID: 314343
    [No Abstract]   [Full Text] [Related]  

  • 5. The lymphocyte response to primary Moloney sarcoma virus tumors: definition of a non-specific component of the in vitro cellular hyporeactivity of tumor-bearing hosts.
    Kiessling R; Bataillon G; Lamon EW; Klein E
    Int J Cancer; 1974 Nov; 14(5):642-8. PubMed ID: 4459279
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.
    Kirchner H; Muchmore AV; Chused TM; Holden HT; Herberman RB
    J Immunol; 1975 Jan; 114(1 Pt 1):206-10. PubMed ID: 122986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antibody to theta antigen on cell-mediated immunity induced in syngeneic mice by murine sarcoma virus.
    Herberman RB; Nunn ME; Lavrin DH; Asofsky R
    J Natl Cancer Inst; 1973 Nov; 51(5):1509-12. PubMed ID: 4543478
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus.
    Kirchner H; Chused TM; Herberman RB; Holden HT; Lavrin DH
    J Exp Med; 1974 Jun; 139(6):1473-87. PubMed ID: 4598016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nonspecific helper effect of mixed lymphocyte reactions on the induction of T cell-mediated immunity in vitro.
    Altman A; Cohen IR
    Eur J Immunol; 1974 Aug; 4(8):577-80. PubMed ID: 4278331
    [No Abstract]   [Full Text] [Related]  

  • 10. Suppression of cell-mediated cytotoxicity by lymphocytes from tumor-bearing animals.
    Hellström I; Hellström KE; Kall MA; Nelson K; Pollack S
    Transplant Proc; 1976 Jun; 8(2):255-64. PubMed ID: 936286
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhancement of normal lymphocyte cytotoxicity by sera with high antibody titers against H-2 or virus-associated antigens.
    Harada M; Pearson G; Pettigrew H; Redmon L; Orr T
    Cancer Res; 1973 Nov; 33(11):2886-93. PubMed ID: 4583975
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms by which tumors avoid destruction by the immune system BCG-catalyzed increase in IgG and IgA blocking activity of lymphocyte-mediated cytotoxicity.
    Hakim AA
    Klin Wochenschr; 1975 Sep; 53(18):881-3. PubMed ID: 1100900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization to effector lymphocytes associated with immunity to murine sarcoma virus (MSV)-induced tumors. II. Repeated stimulation and proliferation in vitro of specific cytolytic T lymphocytes.
    Plata F; Jongeneel CV
    J Immunol; 1977 Aug; 119(2):623-9. PubMed ID: 196025
    [No Abstract]   [Full Text] [Related]  

  • 14. Estimation of the size of a T-cell-induced lytic lesion.
    Henney CS
    Nature; 1974 May; 249(456):456-8. PubMed ID: 4209916
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antigenic systems of tumors and leukemias induced by oncornaviruses].
    Levy JP; Kourilsky FM
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):741-53. PubMed ID: 4340545
    [No Abstract]   [Full Text] [Related]  

  • 16. Reactivity of steroid-resistant neonatal thymocytes.
    Cohen PL; Mosier DE
    Nature; 1974 Sep; 251(5472):233-4. PubMed ID: 4138862
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional characterization of membrane components of cytotoxic peritoneal exudate T lymphocytes. I. Search for T cell receptor activity in lymphocyte membrane fractions.
    Todd RF; Berke G
    Immunochemistry; 1974 Jun; 11(6):313-20. PubMed ID: 4137675
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellular reactivities associated with theta-antigen disparity.
    Peck AB; Bach FH; Boyse EA
    Transplant Proc; 1973 Dec; 5(4):1611-3. PubMed ID: 4272820
    [No Abstract]   [Full Text] [Related]  

  • 19. Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus.
    Herberman RB; Aoki T; Nunn M; Lavrin DH; Soares N; Gazdar A; Holden H; Chang KS
    J Natl Cancer Inst; 1974 Oct; 53(4):1103-11. PubMed ID: 4139276
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphocyte classes in New Zealand mice. I. Ontogeny and mitogen responsiveness of thymocytes and thymus-derived lymphocytes.
    Stobo JD; Talal N; Paul WE
    J Immunol; 1972 Oct; 109(4):692-700. PubMed ID: 4116356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.